| Particulars |
| Company Name |
Alivus Life Sciences Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
24.55 |
B.V. Rs |
245.70 |
| Sales Rs Cr. |
2,386.88 |
NP Rs Cr. |
481.33 |
| NP Var% |
2.00 |
Div% |
250.00 |
| CPS Rs |
44.20 |
EPS Rs |
39.20 |
| Traded Value(Rs Lakhs) |
82.64 |
52 Week High |
1,260.00 |
| 52 Week Low |
827.00 |
Price BSE |
882.00 |
| Price NSE |
884.00 |
Market Capital(Rs Cr.) |
10,826.57 |
| P/C Ratio |
20.00 |
P/E Ratio |
22.50 |
| Price Vs.BV |
3.59 |
|
| Latest Quarter |
| Year End |
202512 |
Sales Rs Cr. |
672.89 |
| NP Rs Cr. |
168.95 |
NP Var % |
23.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
2,204.90 |
| OPM |
28.73 |
NP |
423.50 |
| NP Var% |
27.32 |
EPS |
45.82 |
| PE |
19.25 |
|
|